Pfizer losing patent for Lipitor this November 2011

I used to own the stocks of Pfizer then I sold it I don’t know why; well probably the company wasn’t giving me value that time.

But I think this time will upset the shareholders again, because Pfizer is losing their patent for Lipitor which brings around 10 billion dollars a year; and Ranbaxy’s exclusive manufacturing rights will end this May; and this will bring the price down to probably $30 to $50 per 30 days compared to $200, and I think it will bring the cost down more since there are lots of generic drug manufacturers competing for this.

 

With this change Pfizer will not be the number one drug maker anymore, they said it will be Sanofi-Aventis as to the number one drug maker according to sales, when
lipitor loses it patent.


Leave a Reply

Your email address will not be published. Required fields are marked *